Experiences gained through the Environmental Classification System for Pharmaceuticals Andreas Woldegiorgis, Ph. D. Conference on Sustainable Development.

Slides:



Advertisements
Similar presentations
Chapter 10 Water-Sediment Studies Jeremy Dyson Basel, Switzerland.
Advertisements

Local emission estimates of pharmaceuticals: case study for Lithuania Jolita Kruopienė Kaunas University of Technology, Institute of Environmental Engineering.
TRP Chapter Chapter 6.8 Site selection for hazardous waste treatment facilities.
Presented by the New Brunswick Lung Association In partnership with Health Canada.
1 An Evaluation of Unused Medicine Disposal Options On Wastewater Treatment Plant Influents Douglas S. Finan – GlaxoSmithKline Matthew D. Garamone - Pfizer.
Pharmaceuticals as environmental pollutants – current situation and ongoing research Christina Rudén Royal Institute of Technology (KTH)
HERA at XXXI CED Kay Fox Human & Environmental Risk Assessment Environmental Risk Assessment under HERA: Challenges and Solutions Kay Fox Chair of the.
Chemistry, Environmental Fate and Transport, Production and Uses Charge Question 2-1: Please comment on whether the information is used appropriately in.
Brian A. Harris-Kojetin, Ph.D. Statistical and Science Policy
Canada/Australia Issues being faced in the regulation of nano-materials Deborah Willcocks – Department of Health and Ageing, Government of Australia Anne-Marie.
1 High Production Volume (HPV) Challenge Program Diane Sheridan Chief, Existing Chemicals Branch, Chemical Control Division, Office of Pollution Prevention.
TRP Chapter Chapter 2.3 Environmental impacts and health risks.
Carcinogen Classification Criteria Patricia Richter Ph.D., DABT Tobacco Products Scientific Advisory Committee June 8, 2010.
Training session File Note and Registration Report, 23 rd October Registration report : Partim Fate and Behavior in the environment 23 rd October.
M. Buzby; J. Tell; L. Ziv; G. Gagliano Merck & Co., Inc., Whitehouse Station, NJ Philadelphia Section of the American Water Resources Association October.
PROTECTFP Work Package 1:- results from questionnaire and overview of tools for chemical assessment.
The Effects of Caffeine and Triclocarban on Gammarus pseudolimnaeus Jim Fietzer Department of Biological Sciences, University of Wisconsin – Whitewater.
Environmental risk assessment of chemicals Paul Howe Centre for Ecology & Hydrology, UK.
1 Development & Evaluation of Ecotoxicity Predictive Tools EPA Development Team Regional Stakeholder Meetings January 11-22, 2010.
Swedish Voluntary Environmental Classification System of Pharmaceuticals on Sustainable Development and Pharmaceuticals, Uppsala 10 November.
EPA Tier I Screening Process and
Implications of Heavy Metals in Sewage Sludge Where Do We Stand on Regulations?
Georgia Institute of Technology Systems Realization Laboratory Reducing Environmental Impact.
1 Persistent, Bioaccumulative and Toxic Pollutants Persistent, Bioaccumulative and Toxic Pollutants Programme (PBT) launched by the EPA in 1998: - Reduce.
Hazard and risk management in Pharmaceutical industry
What Do Toxicologists Do?
Products, Organisms, and Our Environment Created by: Jaclyn Miller for Teacher Name: Class Period: Date:
Environmental Risk Assessment of Pharmaceutical Mixtures: - empirical knowledge, gaps and regulatory options Thomas Backhaus University of Gothenburg
RISK ASSESSMENT AS TOOL FOR POLICY MAKERS Roncak P., Adamkova J., Metelkova M. Slovak Hydrometeorological Institute, Jeseniova 17, Bratislava The.
Effects of Bioaccumulation on Ecosystems
Lsfdlkdfj ;la;fkd theklekrj Girly Grass Dana Devin-Clarke. Sally Brown, Michael Muramoto*, and Michael Doubrava* University of Washington and *King County.
Life Cycle Overview & Resources. Life Cycle Management What is it? Integrated concept for managing goods and services towards more sustainable production.
Charge Question 1-1: Please comment on whether the assessment provides a clear and logical summary of EPA’s approach and analysis. Please provide specific.
INAPPROPRIATELY STORAGED DDT AS A POTENTIAL RISK FOR HUMAN HEALTH AND ENVIRONMENT 6th ALPS-ADRIA SCIENTIFIC WORKSHOP 30 April - 5 May, 2007 Obervellach,
Mike Murray Chair of EFPIA EH&S AHG MPA Conference Uppsala
IAEA International Atomic Energy Agency Roger Seitz Addressing Future Human Actions for Safety Assessment Summary from CSM on Human Action And Intrusion.
Risks from/to Ok Teddy project Definition of Risks probability that a substance or situation will produce harm under specified conditions a combination.
Toxins in Food Chains. Feeding the human population is a big business, economically. To prevent foods from being eaten by pests, we put chemical substances.
Commission’s Communication A renewed vision for the pharmaceutical sector Peter Korytár European Commission – DG Environment Uppsala, 11 November 2009.
U.S. High Production Volume (HPV) Challenge Program Diane Sheridan U.S. EPA, Office of Pollution Prevention and Toxics December 12, 2006.
120 januari 2011 Tamiflu in the environment Caroline Moermond Charles Bodar Lonneke van Leeuwen Mark Montforts Bianca van de Ven Suzanne Wuijts Monique.
1 Selected Current and Suggested Ideas on Uses of HPV Challenge Data Nhan Nguyen US EPA Characterizing Chemicals in Commerce: Using Data on High Production.
Pharmaceuticals in the Environment Pharmaceuticals are increasingly being designed to have higher potency, bioavailability and degradation resistance.
THE BIOSAFETY BILL, 2007 JACARANDA HOTEL, 26 TH JULY 2007.
Environmental impact assessment of steroid hormones R. Laenge, LGE 09 June 2006 Assessment of the impact of selected steroid hormones on biodiversity Reinhard.
An Overview of EDC’s, Pharmaceuticals and Personal Care Products in Our Drinking Water Presented By: Roxanne Russell, Yuh-Chi Niou, Kris McArthur, Amelia.
Health Risk from Consuming POC-Contaminated Fish: Part II. Risk Analysis and Prevention Strategies Michael H. Dong, MPH, DrPA, PhD October, 2007 Readings.
PPCPs: An Emerging Source of Chemical Pollution By: Arienne Barnes Nicolette Foster Aaron Stover Ingrid Tobar Sara Vogt Jennifer Wolfe.
Pollution and Human Health
1 Children and chemical safety: framework for action to protect children from harmful exposures Presented on behalf of the IFCS Children & Chemical Safety.
Measurement and Targeting – Design and Implement Programs to Track Results and Accountability National Environmental Partnership Summit 2006 Wednesday,
Methodologies and Tools for Technology Needs Assessment: an Overview Zou Ji Dept. of environmental Economics and Management, Renmin University of China.
What happens to medicine after you take it?. What are some common medicines or supplements that people take everyday?
A Global Review of Methodologies for Aquatic Ecological Risk Assessment.
COHIBA preliminary results for implementation HELCOM BSAP Ms. Eva Brorström-Lundén, IVL Swedish Environmental Research Institute 32rd Meeting of the Helsinki.
Prioritization Process and Development of the Hazard Characterization Documents Office of Pollution Prevention and Toxics U.S. Environmental Protection.
Task Force on POPs Generic Guidelines and Procedures.
1 State of play and outlook of modelling based prioritisation Klaus Daginnus Institute for Health & Consumer Protection Joint Research Centre, European.
INCREASING THE DIALOGUE BETWEEN SCIENTISTS, POLICY MAKERS AND STAKEHOLDERS SUBERNAREKHA RIVER BASIN, INDIA SOCIO-ECONOMIC ISSUES AND POLICY OPTIONS RAMESH.
Copyright c 2001 The McGraw-Hill Companies, Inc.1 Chapter 5 Research Ethics All researchers, even students, have a responsibility to conduct ethical research.
1. Consumers, Health, Agriculture and Food Executive Agency Risk assessment with regard to food and feed safety Risk analysis Why risk assessment in the.
Abstract A step-wise or ‘tiered’ approach has been used as a rational procedure to conduct environmental risk assessments in many disciplines. The Technical.
Classification. Hazard Classification The GHS is designed to identify and classify the “hazards” of the substances or mixtures, and to communicate those.
Sustainable Development Goal for Water: Indicator 6.3.2
Communication: Safety Summary
Bioaccumulation, PBTs, and SVHCs Day 2.
ASSESSING THE ENVIRONMENTAL CONSEQUENCE OF POTENTIAL MAJOR ACCIDENTS
Directive 2006/118/EC Short overview
Addressing Future Human Actions for Safety Assessment
Presentation transcript:

Experiences gained through the Environmental Classification System for Pharmaceuticals Andreas Woldegiorgis, Ph. D. Conference on Sustainable Development and Pharmaceuticals, Uppsala 10-11/11, 2009

Woldegiorgis, Uppsala 10/ Overview Background The PEC/PNEC relationship PEC and human metabolism PEC and STP-removal PNEC data in the fass.se system The role of the system reviewer A case study from the fass.se system Conclusions

Woldegiorgis, Uppsala 10/ Background; Effects in the environment (and in the media..) Frogs, fish and pharmaceuticals a troubling brew Prozac, other drugs detected in streams and their inhabitants By Marsha Walton CNN Friday, November 14, 2003 Posted: 9:14 AM EST (1414 GMT) Two tapdpoles after 57 days of development in the lab. The one on the right, which has yet to sprout limbs, was exposed to fluoxetine, also known as Prozac. (CNN) -- A number of aquatic and amphibian species are being exposed to small amounts of everything from Prozac to perfume to birth control pills that make their way into U.S. rivers and streams. And scientists now have evidence that this "cocktail" of pharmaceuticals, in high enough quantities, can lead to problems that may be serious enough to prevent wildlife from reproducing. It's not yet clear how the buildup over time could affect the species. In 2002, 80 percent of streams sampled by the U.S. Geological Survey showed evidence of drugs, hormones, steroids and personal care products such as soaps and perfumes. The U.S.G.S. tested 139 rivers in 30 states.

Woldegiorgis, Uppsala 10/ Approximatively 550 peer-reviewed articles published on the issue "pharmaceuticals in the environment" between ~ 65 % published rather recently, 2006 and onwards... Or;

Woldegiorgis, Uppsala 10/ Thus; Any classification system of the environmental risks of pharmaceuticals implemented 2005 must be considered as a 'living' system in which improvements and new methodology can easily be implemented.

Woldegiorgis, Uppsala 10/ Basic principles of Environmental Risk Assessment (ERA) PEC / PNEC Predicted Environmental Concentration Predicted No Effect Concentration Predicted concentration of the substance in the environment is related to the toxicity of the substance towards organisms living in the environment.

Woldegiorgis, Uppsala 10/ Estimation of the Surface water PEC in µg/l "A" ; sold amount annually [kg] Consumption in kg PEC = Nr of liters of water that the Swedish population uses annually Thus, the system requires an exact estimation of the sold amount of any given pharmaceutical!!! Or, in a simplified way...

Woldegiorgis, Uppsala 10/ Refinement (reduction...) of the PEC-value possible; Metabolism in the human body; from the fass.se-guideline; "...Identification of the metabolites, including specification of conjugates, which may de-conjugate to the parent compound in a sewage treatment plant....Pharmacological activity (or eco-toxicity, if known) of the metabolites compared with the parent compound." Fate of the pharmaceutical upon passage of the waste water treatment plant; If no eco-toxicological data on the main metabolite can be found, PEC should NOT be reduced based on metabolism! PEC-reduction should be based on either the SimpleTreat-model, OECD 303-experiments, or extensive measurements! SimpleTreat (Strujis J, 1996, TGD (Ref. 4), Part II, Chapter 3, Appendix II) "R" = f (OECD301/302-data, logH and logKow)

Woldegiorgis, Uppsala 10/ The PNEC data in the fass.se system; Data should reflect tests performed on 3 trophic levels; algae, crustaceans and fish. In order to ensure acceptable safety margin when going from lab tests on x individuals to an entire population in the environment; a safety factor (AF) is applied. Thus; If only short term acute data available then AF = If chronic long-term data are available from all 3 trophic levels, then AF = 10

Woldegiorgis, Uppsala 10/ PNEC data in the fass.se-system are mostly; 1) provided by the companies from standard tests performed during the ERA process. 2) reflecting acute and short-term testing conditions (thus seldom chronic data) 3) mostly data not taking the specific mode-of-action of the pharmaceutical into consideration 4) never 'calculated' or estimated based on structure-activity relationships (SARs/QSARs) Consequently, PNEC data currently used leave room for improvements when more appropriate data becomes available!!

Woldegiorgis, Uppsala 10/ One important remark before we continue....  PEC and PNEC data on all available substances are transparently displayed at the fass.se website (for anybody to check/audit) (along with data on biodegradation and bioaccumulation). The transparency (and availability) renders the system attractive to anybody interested; ( authorities, stake holders, other companies ).  Which other environmental classification systems possesses this property?

Woldegiorgis, Uppsala 10/ The role of IVL Swedish Environmental Research Institute in the fass.se-project  To scientifically review the environmental risk-and hazard data supplied by the pharmarceutical companies.  To comment the supplied risk assessments submitted and recommend improvements to ensure; 1.compatibility with the fass.se guideline, 2.that data chosen seem appropriate with respect to methodology used, 3.that the overall traceability of the data meets the guideline requirements.  To suggest improvements of the guideline to the environmental committée of LIF.  To summarize the data accumulated on fass.se to some general and overall synthese, beneficial to the stakeholders ( at the end of the project ).

Woldegiorgis, Uppsala 10/ Important considerations of the reviewing process  No direct contact between IVL-reviewers and pharmaceutical companies, all communication and data iteration through the LIF office.  A self-declaration system where the pharmaceutical companies "owns" their respective data. IVL does not 'police' the published material beyond the reviewing process.  The system is a classification system with a broad perspective, hence sometimes difficult to implement latest scientific findings from the research frontier.

Woldegiorgis, Uppsala 10/ Case study; Fass.se-data may not always be enough to make environmentally good choices!  Sertraline and Citalopram considered equally good on some indications of depression (therapeutic effect of treatment).  PNEC (Sertraline) = µg/l  PNEC (Citalopram) =4.9 µg/l ("Sertraline 88 times more "toxic"..)  Both "have the potential to bioaccumulate" (log Kow > 3)  Sertraline; "slowly degraded"  Citalopram; "potentially persistent" (due to lack of data)  PEC/PNEC (Sertraline) = 6.6  PEC/PNEC (Citalopram) = 0.05  Sertraline poses a 132 times higher environmental risk, nationally...  Best 'choice' would be Citalopram, right?

Woldegiorgis, Uppsala 10/ IVL Screening data on STP effluents Citalopram detected in all STP effluents; ng/l Sertraline never detected in any of the 28 effluents

Woldegiorgis, Uppsala 10/ Fate of Sertraline ? Detected in all digested sludge samples; 1.6 – 310 ng/g DW In Stockholm; Citalopram easily reaches the the archipelago through the effluent discharge in Saltsjön while Sertraline-contaminated sludge is transported 2000 km to Lapponia where it is used as landfill! Which is the more favourable choice for the environment? IVL Screening data on digested sludge

Woldegiorgis, Uppsala 10/ Conclusions  Scientific reviewing of the fass.se-data should safeguard that data and methods are in accd. with guidelines (fass.se and TGD) and that the interpretation of data is in accd. with the precautionary principle.  Scientific reviewing of the fass.se-data not always straightforward, many "special cases" not entirely covered by guidelines". The guideline is thus a 'living' document.  Fass.se-data can perferably be combined with occurence data and some kind of scientific rationale, fass.se is not a "bible" for ERA!  The total transparency of the fass.se system makes it unique as a classification system.  The system can be transferred to other countries!